U.S. judge tosses $140 million verdict against AbbVie in AndroGel case

(Reuters) - A U.S. judge on Thursday overturned a $140 million verdict against AbbVie Inc in a lawsuit by a man who claimed the company misrepresented the risks of its testosterone replacement drug AndroGel, causing him to suffer a heart attack.

Source: Reuters: Health - July 5, 2018 Category: Consumer Health News Tags: healthNews Source Type: news